ALK and ROS1 concurrent with EGFR mutation in patients with lung adenocarcinoma

摘要

PurposeThe purpose of this study was to explore the frequencies of ALK and ROS1 fusion genes in EGFR-mutant lung adenocarcinoma patients and examine the therapeutic efficacies of EGFR-tyrosine kinase inhibitors (TKIs).